Michael Schreiber to Ductus Arteriosus, Patent
This is a "connection" page, showing publications Michael Schreiber has written about Ductus Arteriosus, Patent.
Connection Strength
0.075
-
Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr. 2008 Aug; 153(2):183-9.
Score: 0.069
-
Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants. J Pediatr. 1993 Mar; 122(3):438-45.
Score: 0.006